Literature DB >> 15761760

Visual function in Vogt-Koyanagi-Harada patients.

Soon-Phaik Chee1, Chi D Luu, Ching-Li Cheng, Wee-Kiak Lim, Aliza Jap.   

Abstract

BACKGROUND: Vogt-Koyanagi-Harada (VKH) disease presents with anterior segment inflammation, choroiditis and exudative retinal detachment. Following resolution of the inflammation, VKH patients have been noted to complain of visual disturbances despite good visual acuity. We therefore investigated the visual function deficits of convalescent VKH patients.
METHODS: A cross-sectional observational nonrandomized controlled study of convalescent VKH patients from the Uveitis Service of the Singapore National Eye Centre, and normal subjects was performed. The best-corrected visual acuities (BCVA) and multifocal electroretinograms (mfERGs) of VKH patients with and without peripapillary atrophy (PPA) were compared with those of the normal eyes. The mfERG results were subdivided into those obtained from the peripapillary area and those from the rest of the macular.
RESULTS: Eleven VKH eyes with large PPA to disc ratios (PPA/D ratio >2), 15 VKH eyes with PPA/D ratios<1 and 6 normal eyes were included in the study. Five eyes (54.5%) of VKH patients with PPA/D>2 had a BCVA of less than 20/40. All the other eyes had 20/20 vision. Nine of the 11 VKH eyes with PPA/D>2 also had large areas of chorioretinal atrophy. The mfERG responses of VKH eyes with PPA/D ratio >2 were markedly reduced in amplitude (p<0.001) and delayed in implicit time (p<0.001) throughout the entire macular area. VKH patients with PPA/D ratio<1 had significantly reduced mfERG amplitudes throughout the entire macular area, as well as delayed implicit times at the peripapillary region (p=0.026). Sub-division of VKH eyes with PPA/D<1 into eyes with no PPA and eyes with a small PPA, showed that both groups had a similar reduction in response amplitude over the entire macular region. However, the implicit time was significantly delayed in eyes with small PPA when compared to those without PPA (p<0.03).
CONCLUSIONS: VKH patients with large PPA have clinically significant visual dysfunction. VKH patients without PPA also have subclinical retinal dysfunction. The mfERG may be a useful adjunct in the management of VKH by detecting early retinal damage.

Entities:  

Mesh:

Year:  2005        PMID: 15761760     DOI: 10.1007/s00417-005-1156-3

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  18 in total

1.  Acute idiopathic blind spot enlargement syndrome: prolonged retinal dysfunction revealed by multifocal electroretinogram technique.

Authors:  N Kondo; M Kondo; Y Miyake
Journal:  Am J Ophthalmol       Date:  2001-07       Impact factor: 5.258

2.  The contribution of indocyanine green angiography to the appraisal and management of Vogt-Koyanagi-Harada disease.

Authors:  N Bouchenaki; C P Herbort
Journal:  Ophthalmology       Date:  2001-01       Impact factor: 12.079

3.  Extensive chorioretinal atrophy in Vogt-Koyanagi-Harada disease.

Authors:  S Sonoda; K Nakao; N Ohba
Journal:  Jpn J Ophthalmol       Date:  1999 Mar-Apr       Impact factor: 2.447

4.  Quantitative evaluation of "sunset glow" fundus in Vogt-Koyanagi-Harada disease.

Authors:  S Suzuki
Journal:  Jpn J Ophthalmol       Date:  1999 Jul-Aug       Impact factor: 2.447

5.  Complications and prognostic factors in Vogt-Koyanagi-Harada disease.

Authors:  R W Read; A Rechodouni; N Butani; R Johnston; L D LaBree; R E Smith; N A Rao
Journal:  Am J Ophthalmol       Date:  2001-05       Impact factor: 5.258

6.  Depigmented atrophic lesions in sunset glow fundi of Vogt-Koyanagi-Harada disease.

Authors:  H Inomata; N A Rao
Journal:  Am J Ophthalmol       Date:  2001-05       Impact factor: 5.258

7.  Clinical and histopathologic observations in severe Vogt-Koyanagi-Harada syndrome.

Authors:  H D Perry; R L Font
Journal:  Am J Ophthalmol       Date:  1977-02       Impact factor: 5.258

8.  Videofunduscopy and videoangiography using the scanning laser ophthalmoscope in Vogt-Koyanagi-Harada syndrome.

Authors:  A A Okada; T Mizusawa; J Sakai; M Usui
Journal:  Br J Ophthalmol       Date:  1998-10       Impact factor: 4.638

9.  Clinical studies of Vogt-Koyanagi-Harada's disease.

Authors:  S Ohno; R Minakawa; H Matsuda
Journal:  Jpn J Ophthalmol       Date:  1988       Impact factor: 2.447

10.  Clinical studies of Vogt-Koyanagi-Harada's disease at the National Eye Institute, NIH, USA.

Authors:  R B Nussenblatt
Journal:  Jpn J Ophthalmol       Date:  1988       Impact factor: 2.447

View more
  8 in total

1.  Full-field electroretinogram behavior in Vogt-Koyanagi-Harada disease: a 24-month longitudinal study in patients from acute onset evaluated with multimodal analysis.

Authors:  Viviane Mayumi Sakata; Marcelo Mendes Lavezzo; Felipe T da Silva; Ever Ernesto Caso Rodriguez; Celso Morita; Smairah Frutuoso Abdallah; Maria Kiyoko Oyamada; Carlos Eduardo Hirata; Joyce Hisae Yamamoto
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-08-22       Impact factor: 3.117

2.  The effect on choroidal changes of the route of systemic corticosteroids in acute Vogt-Koyanagi-Harada disease.

Authors:  Un Chul Park; In Hwan Cho; Eun Kyung Lee; Hyeong Gon Yu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-04-05       Impact factor: 3.117

3.  Alterations of color vision and central visual field in patients with Vogt-Koyanagi-Harada syndrome.

Authors:  Peizeng Yang; Min Sun; Xiaoli Liu; Hongyan Zhou; Wang Fang; Li Wang; Aize Kijlstra
Journal:  J Ophthalmic Inflamm Infect       Date:  2012-02-02

Review 4.  Electrophysiological examination in uveitis: a review of the literature.

Authors:  Marilita M Moschos; Nikolaos S Gouliopoulos; Christos Kalogeropoulos
Journal:  Clin Ophthalmol       Date:  2014-01-10

Review 5.  Vogt-Koyanagi-Harada syndrome - current perspectives.

Authors:  Abeir Baltmr; Sue Lightman; Oren Tomkins-Netzer
Journal:  Clin Ophthalmol       Date:  2016-11-24

6.  Identification of Underlying Inflammation in Vogt-Koyanagi-Harada Disease with Sunset Glow Fundus by Multiple Analyses.

Authors:  Toshihiko Murata; Nanae Sako; Kei Takayama; Kozo Harimoto; Koji Kanda; Carl P Herbort; Masaru Takeuchi
Journal:  J Ophthalmol       Date:  2019-10-03       Impact factor: 1.909

Review 7.  Influence of molecular genetics in Vogt-Koyanagi-Harada disease.

Authors:  Joanne Yw Ng; Fiona Oj Luk; Timothy Yy Lai; Chi-Pui Pang
Journal:  J Ophthalmic Inflamm Infect       Date:  2014-07-22

Review 8.  Vogt-Koyanagi-Harada disease: review of a rare autoimmune disease targeting antigens of melanocytes.

Authors:  Marcelo Mendes Lavezzo; Viviane Mayumi Sakata; Celso Morita; Ever Ernesto Caso Rodriguez; Smairah Frutuoso Abdallah; Felipe T G da Silva; Carlos Eduardo Hirata; Joyce Hisae Yamamoto
Journal:  Orphanet J Rare Dis       Date:  2016-03-24       Impact factor: 4.123

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.